Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9388501 | 0.93 | NPSR1 (0.44) | CYP1A2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL4763549 | 0.86 | CA1 (0.39) | MEN1KMT2ACA1CA2CA9 | |
| SCHEMBL17881929 | 0.78 | ESR2 (0.39) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL9115160 | 0.78 | ALDH1A1 (0.41) | LMNAMAOANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9714337 | 0.78 | ESR2 (0.39) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL28950890 | 0.77 | PREP (0.46) | MAOAMAOBCYP1A2CYP2C19CYP2C9 | |
| SCHEMBL11233031 | 0.76 | CA1 (0.61) | CYP2A6CYP1A2CYP2C9NPC1RAB9A | |
| SCHEMBL2016960 | 0.76 | ACHE (0.50) | LMNACYP2C9NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10879582 | 0.75 | HPGD (0.41) | LMNACYP2A6MAOAMAOBCYP1A2 | |
| SCHEMBL10406632 | 0.75 | CA1 (0.40) | LMNACYP2A6MAOAMAOBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114702372-B | Method for preparing 4- (2-methoxyl) ethylphenol | 台州市前进化工有限公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-114702372-A | Method for preparing high-purity 4- (2-methoxy) ethylphenol | 台州市前进化工有限公司 | 2022-07-05 | — | — | CN | disclosed |
| US-9908908-B2 | Tenofovir prodrug and pharmaceutical uses thereof | JIANGSU HANSOH PHARMACEUTICAL CO., LTD. (CN) | 2018-03-06 | — | — | US | disclosed |
| EP-2891658-B1 | TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF | JIANGSU HANSOH PHARMACEUTICAL CO LTD (CN) | 2017-05-31 | — | — | EP | disclosed |
| US-20150225433-A1 | TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2015-08-13 | — | — | US | disclosed |
| EP-2891658-A1 | TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF | Jiangsu Hansoh Pharmaceutical Co., Ltd. (CN) | 2015-07-08 | — | — | EP | disclosed |
| CN-103193606-B | Synthesis method of brominated phenolic compound | HARBIN INST OF TECHNOLOGY | 2015-04-08 | — | — | CN | disclosed |
| CN-103193606-A | Synthesis method of brominated phenolic compound | HARBIN INST OF TECHNOLOGY | 2013-07-10 | — | — | CN | disclosed |
| US-8293905-B2 | Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8088883-B2 | Transition metal complex and process for producing conjugated aromatic compound using the transition metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20110046336-A1 | TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED | 2011-02-24 | — | — | US | disclosed |
| US-20100184978-A1 | BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-22 | — | — | US | disclosed |
| CN-101772508-A | Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex | SUMITOMO CHEMICAL CO | 2010-07-07 | — | — | CN | disclosed |
| EP-2192124-A1 | TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND WITH THE TRANSITION METAL COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2010-06-02 | — | — | EP | disclosed |
| EP-2172470-A1 | BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-5998509-A | BLEND OF AN EPOXY RESIN, POLYSILOXANE CURING AGENT AND FILLER | KABUSHIKI KAISHA TOSHIBA (JP) | 1999-12-07 | — | — | US | disclosed |
| US-5622784-A | WATERPROOFING; MODIFIED SILICON DIOXIDE THIN FILM | SEIKO EPSON CORPORATION (JP) | 1997-04-22 | — | — | US | disclosed |
| EP-0342494-B1 | Light-sensitive composition and process for the formation of relief patterns | BASF AG (DE) | 1993-12-29 | — | — | EP | disclosed |
| US-5069998-A | RADIATION SENSITIVE MIXTURE AND PRODUCTION OF RELIEF PATTERNS | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-03 | — | — | US | disclosed |
| EP-0342494-A2 | Light-sensitive composition and process for the formation of relief patterns | BASF Aktiengesellschaft (DE) | 1989-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046336-A1 | TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | C9, C5, AP1M1 | LMNA 2664/4885CYP2A6 878/4885MAOA 278/4885 |
| US-20100184978-A1 | BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | C9, C5, AP2M1 | LMNA 3345/4885CYP2A6 490/4885MAOA 489/4885 |
| US-20150225433-A1 | TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF | SLC10A1, HPRT1, SLC5A1 | LMNA 2108/4885CYP2A6 55/4885MAOA 2831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.